Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials (Q42292313)
Jump to navigation
Jump to search
scientific article published on 2 March 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials |
scientific article published on 2 March 2017 |
Statements
1 reference
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials (English)
1 reference
Richard J Gralla
1 reference
Fatima Ahmad
1 reference
Jaime D Blais
1 reference
Joseph Chiodo
1 reference
Wen Zhou
1 reference
Linda A Glaser
1 reference
Frank S Czerwiec
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference